Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thailand Could Seek WTO Solution On Compulsory Licensing, Generic Drugs

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Multinational drug companies and authorities across developed countries have censured Thailand for using compulsory licensing - a method of forcing pharmaceutical outfits holding patents on innovative medicines to allow other companies to turn out the product

You may also be interested in...



After Ending Protests, Thai Leadership Aims To Reassure Foreign Firms, Investors

SHANGHAI - After using the military to clear Bangkok of protesters, the Thai government is mounting a peaceful offensive, armed with an arsenal of favorable tax and investment policies, to encourage international businesses to stay put or set up shop in Thailand

After Ending Protests, Thai Leadership Aims To Reassure Foreign Firms, Investors

SHANGHAI - After using the military to clear Bangkok of protesters, the Thai government is mounting a peaceful offensive, armed with an arsenal of favorable tax and investment policies, to encourage international businesses to stay put or set up shop in Thailand

China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices

BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation

Related Content

UsernamePublicRestriction

Register

SC074408

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel